BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29273365)

  • 1. Sinusoidal protection by sphingosine-1-phosphate receptor 1 agonist in liver ischemia-reperfusion injury.
    Ito T; Kuriyama N; Kato H; Matsuda A; Mizuno S; Usui M; Sakurai H; Isaji S
    J Surg Res; 2018 Feb; 222():139-152. PubMed ID: 29273365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiapoptotic Effect by PAR-1 Antagonist Protects Mouse Liver Against Ischemia-Reperfusion Injury.
    Noguchi D; Kuriyama N; Ito T; Fujii T; Kato H; Mizuno S; Sakurai H; Isaji S
    J Surg Res; 2020 Feb; 246():568-583. PubMed ID: 31653415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-Phosphate Receptor-1 Selective Agonist Enhances Collateral Growth and Protects against Subsequent Stroke.
    Ichijo M; Ishibashi S; Li F; Yui D; Miki K; Mizusawa H; Yokota T
    PLoS One; 2015; 10(9):e0138029. PubMed ID: 26367258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice.
    Iwasawa E; Ishibashi S; Suzuki M; Li F; Ichijo M; Miki K; Yokota T
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1237-1251. PubMed ID: 29337049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate receptor 1 agonist SEW2871 prolongs heterotopic heart allograft survival in mice.
    Ni Q; Yuan B; Liu T; Lan F; Luo X; Lu X; Huang P; Dai L; Jin X; Yin H
    Int Immunopharmacol; 2015 May; 26(1):37-42. PubMed ID: 25776899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Dabigatran Treatment on Sinusoidal Protection Against Hepatic Ischemia/Reperfusion Injury in Mice.
    Noguchi D; Kuriyama N; Hibi T; Maeda K; Shinkai T; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Tanemura A; Murata Y; Kishiwada M; Sakurai H; Mizuno S
    Liver Transpl; 2021 Feb; 27(3):363-384. PubMed ID: 33108682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure.
    Lien YH; Yong KC; Cho C; Igarashi S; Lai LW
    Kidney Int; 2006 May; 69(9):1601-8. PubMed ID: 16572108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
    Stone ML; Sharma AK; Zhao Y; Charles EJ; Huerter ME; Johnston WF; Kron IL; Lynch KR; Laubach VE
    Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(12):L1245-52. PubMed ID: 25910934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
    Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
    J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury.
    Bajwa A; Jo SK; Ye H; Huang L; Dondeti KR; Rosin DL; Haase VH; Macdonald TL; Lynch KR; Okusa MD
    J Am Soc Nephrol; 2010 Jun; 21(6):955-65. PubMed ID: 20338995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation.
    Park SW; Kim M; Chen SW; Brown KM; D'Agati VD; Lee HT
    Lab Invest; 2010 Aug; 90(8):1209-24. PubMed ID: 20458275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in Sepsis.
    Flemming S; Burkard N; Meir M; Schick MA; Germer CT; Schlegel N
    Shock; 2018 Jan; 49(1):71-81. PubMed ID: 28538086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-linked kinase regulates endothelial cell nitric oxide synthase expression in hepatic sinusoidal endothelial cells.
    Shafiei MS; Lui S; Rockey DC
    Liver Int; 2015 Apr; 35(4):1213-21. PubMed ID: 24906011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate promotes the proliferation and attenuates apoptosis of Endothelial progenitor cells via S1PR1/S1PR3/PI3K/Akt pathway.
    Wang H; Huang H; Ding SF
    Cell Biol Int; 2018 Nov; 42(11):1492-1502. PubMed ID: 29790626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: Role of intracellular calcium and nitric oxide.
    Zheng DM; Kitamura T; Ikejima K; Enomoto N; Yamashina S; Suzuki S; Takei Y; Sato N
    Hepatology; 2006 Nov; 44(5):1278-87. PubMed ID: 17058266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.
    Burg N; Swendeman S; Worgall S; Hla T; Salmon JE
    Arthritis Rheumatol; 2018 Nov; 70(11):1879-1889. PubMed ID: 29781582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice.
    Dong J; Wang H; Wu G; Zhao J; Zhang L; Zuo L; Zhu W; Gong J; Li Y; Gu L; Li J
    Clin Exp Immunol; 2014 Jul; 177(1):94-101. PubMed ID: 24611843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin preconditioning attenuates liver ischemia reperfusion injury through the phosphatidylinositol-3 kinase/AKT/endothelial nitric oxide synthase pathway.
    Fu W; Liao X; Ruan J; Li X; Chen L; Wang B; Wang K; Zhou J
    J Surg Res; 2013 Aug; 183(2):876-84. PubMed ID: 23490139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.